Suppr超能文献

Kv7 钾通道的激活抑制 TRPV1 介导的痛觉诱导刺激引起的 F11 永生化感觉神经元内 Ca2+的增加。

Activation of Kv7 Potassium Channels Inhibits Intracellular Ca Increases Triggered By TRPV1-Mediated Pain-Inducing Stimuli in F11 Immortalized Sensory Neurons.

机构信息

Department of Science and Technology, University of Sannio, 82100 Benevento, Italy.

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

出版信息

Int J Mol Sci. 2019 Sep 4;20(18):4322. doi: 10.3390/ijms20184322.

Abstract

Kv7.2-Kv7.5 channels mediate the M-current (I), a K-selective current regulating neuronal excitability and representing an attractive target for pharmacological therapy against hyperexcitability diseases such as pain. Kv7 channels interact functionally with transient receptor potential vanilloid 1 (TRPV1) channels activated by endogenous and/or exogenous pain-inducing substances, such as bradykinin (BK) or capsaicin (CAP), respectively; however, whether Kv7 channels of specific molecular composition provide a dominant contribution in BK- or CAP-evoked responses is yet unknown. To this aim, Kv7 transcripts expression and function were assessed in F11 immortalized sensorial neurons, a cellular model widely used to assess nociceptive molecular mechanisms. In these cells, the effects of the pan-Kv7 activator retigabine were investigated, as well as the effects of ICA-27243 and (S)-1, two Kv7 activators acting preferentially on Kv7.2/Kv7.3 and Kv7.4/Kv7.5 channels, respectively, on BK- and CAP-induced changes in intracellular Ca concentrations ([Ca]). The results obtained revealed the expression of transcripts of all genes, leading to an I-like current. Moreover, all tested Kv7 openers inhibited BK- and CAP-induced responses by a similar extent (60%); at least for BK-induced Ca responses, the potency of retigabine (IC1 µM) was higher than that of ICA-27243 (IC5 µM) and (S)-1 (IC7 µM). Altogether, these results suggest that I activation effectively counteracts the cellular processes triggered by TRPV1-mediated pain-inducing stimuli, and highlight a possible critical contribution of Kv7.4 subunits.

摘要

Kv7.2-Kv7.5 通道介导 M 电流(I),一种 K 选择性电流,调节神经元兴奋性,是治疗过度兴奋疾病(如疼痛)的有吸引力的药物靶点。Kv7 通道与瞬时受体电位香草酸 1 型(TRPV1)通道相互作用,后者被内源性和/或外源性致痛物质激活,如缓激肽(BK)或辣椒素(CAP);然而,特定分子组成的 Kv7 通道是否对 BK 或 CAP 诱发的反应提供主要贡献尚不清楚。为此,在 F11 永生化感觉神经元中评估 Kv7 转录本的表达和功能,该细胞模型广泛用于评估伤害性分子机制。在这些细胞中,研究了泛 Kv7 激活剂 retigabine 的作用,以及 ICA-27243 和 (S)-1 的作用,这两种 Kv7 激活剂分别优先作用于 Kv7.2/Kv7.3 和 Kv7.4/Kv7.5 通道,对 BK 和 CAP 诱导的细胞内 Ca 浓度变化([Ca])的影响。结果表明,所有基因的转录本都表达了一种 I 样电流。此外,所有测试的 Kv7 开放剂以相似的程度(60%)抑制 BK 和 CAP 诱导的反应;至少对于 BK 诱导的 Ca 反应,retigabine(IC1 µM)的效力高于 ICA-27243(IC5 µM)和 (S)-1(IC7 µM)。综上所述,这些结果表明 I 激活有效地抵消了 TRPV1 介导的致痛刺激引发的细胞过程,并突出了 Kv7.4 亚基的可能关键贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/452d/6769798/8fc833b33bce/ijms-20-04322-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验